Manufacturers Don’t Forget: Virginia Drug Pricing Reports are Due April 1st Written-by: Deneen Fumich, RPh March 2021, Virginia passed the Prescription Drug Price Transparency Regulation requiring pharmaceutical manufacturers to annually report prescription drug...
Do Drug Price Transparency Laws Need to Explicitly Define Reporting Entities? Written-by: Deneen Fumich, RPh With the wave of 2021 passed Drug Price Transparency “DPT” laws now moving into rulemaking, is the industry finding it difficult to determine who a “Reporting...
Importance of Current Good Manufacturing Practices (cGMP) Written-by: Deneen Fumich, RPh Did you know that a common cause of failing FDA inspections is a gap in or the outdated training of employees in current good manufacturing practices (cGMP) compliance, as well as...
